Successful rescue pneumovesicoscopic surgery for post-Deflux® vesicoureteral junction obstruction
- PMID: 37642740
- DOI: 10.1007/s00383-023-05538-3
Successful rescue pneumovesicoscopic surgery for post-Deflux® vesicoureteral junction obstruction
Abstract
Background: Vesicoureteral junction (VUJ) obstruction after Deflux® subureteral injection for vesicoureteral reflux (VUR) is rare and minimally invasive management has not been reported. This work investigated the patients who underwent Deflux® injection for VUR and identified those with subsequent VUJ obstruction.
Methods: Medical records of matched patients from October 2003 to March 2022 were reviewed, and parameters were retrospectively studied. All patients underwent Deflux® injection. The injection was performed under general anesthesia using the same manner. For patients complicated with VUJ obstruction, the symptoms, signs, management, images, renal ultrasounds, Tc-99m dimercaptosuccinic acid renal scintigraphy, histology of VUJ region, and outcomes were documented and reported. VUJ stenosis was diagnosed by performing renal ultrasound and magnetic resonance imaging.
Results: Totally 407 patients (554 ureterorenal units) received Dx/HA injections for VUR. VUJ obstruction was found in three patients (four ureterorenal units). Originally, three were grade V VUR, and one was grade IV. The repeated injection was not a risk factor for VUJ obstruction. The overall incidence of VUJ obstruction post-Dx/HA injection was 0.7% by ureter. The incidences were 0%, 0.75%, and 2.25% for grade I-III, IV, and V VUR, respectively. After the initial conversion case of pneumovesicoscopic ureteral reimplantation, the procedure was performed smoothly and successfully in the two following cases.
Conclusions: Pneumovesicoscopic ureteral reimplantation offers an alternative for VUJ obstruction following Dx/HA injection for VUR. Fibrosis and foreign-body reaction may influence the feasibility. High-grade VUR and young age of injection were related to VUJ obstruction.
Keywords: Dextranomer/hyaluronic acid; Pneumovesicoscopy; Ureteral reimplantation; Vesicoureteral junction obstruction; Vesicoureteral reflux.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.J Laparoendosc Adv Surg Tech A. 2018 Mar;28(3):348-353. doi: 10.1089/lap.2017.0281. Epub 2017 Dec 22. J Laparoendosc Adv Surg Tech A. 2018. PMID: 29271690
-
Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.J Pediatr Urol. 2018 Dec;14(6):554.e1-554.e6. doi: 10.1016/j.jpurol.2018.07.006. Epub 2018 Jul 24. J Pediatr Urol. 2018. PMID: 30146426
-
Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.J Urol. 2003 Jul;170(1):211-5. doi: 10.1097/01.ju.0000072523.43060.a0. J Urol. 2003. PMID: 12796692
-
A systematic review of outcomes of Deflux® treatment for vesicoureteral reflux following pediatric renal transplantation.J Pediatr Urol. 2021 Aug;17(4):589.e1-589.e6. doi: 10.1016/j.jpurol.2021.07.012. Epub 2021 Jul 17. J Pediatr Urol. 2021. PMID: 34364813
-
Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter?Curr Urol Rep. 2019 Jul 9;20(9):49. doi: 10.1007/s11934-019-0913-5. Curr Urol Rep. 2019. PMID: 31289951 Review.
References
-
- Baydilli N, Selvi I, Pinarbasi AS et al (2021) Additional VCUG-related parameters for predicting the success of endoscopic injection in children with primary vesicoureteral reflux. J Pediatr Urol 17(1):68e1-68e8 - DOI
-
- Nordenstrom J, Holmdahl G, Brandstrom P et al (2017) The Swedish infant high-grade reflux trial: study presentation and vesicoureteral reflux outcome. J Pediatr Urol 13(2):130–138. https://doi.org/10.1016/j.jpurol.2016.08.026 - DOI - PubMed
-
- Puri P, Kutasy B, Colhoun E et al (2012) Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol 188(4 Suppl):1485–1489. https://doi.org/10.1016/j.juro.2012.02.023 - DOI - PubMed
-
- Coplen DE (2011) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. Yearb Urol 2011:207–208. https://doi.org/10.1016/j.yuro.2010.12.004 - DOI
-
- Tekgul S, Riedmiller H, Hoebeke P et al (2012) EAU guidelines on vesicoureteral reflux in children. Eur Urol 62(3):534–542. https://doi.org/10.1016/j.eururo.2012.05.059 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources